All team members
German Patent Attorney
European Patent Attorney
Representative before the UPC
Eva represents European, US and Japanese companies in the chemical, biochemical and pharmaceutical sectors whom she advises and assists in prosecuting, defending, enforcing and challenging IP rights in Germany, Europe and worldwide. Along with preparing freedom-to-operate and validity analyses she has experience in patent litigation and strategic patent ﬁling, especially in the area of drug delivery, pharmaceutics and medical uses (small molecules and biologics) as well as in coordinating international patent portfolios and freedom-to-operate strategies. Eva has received numerous recognitions for her professional activities as a patent attorney.
"Eva Ehlich is a brilliant, highly experienced and dedicated attorney combining an impressive degree of long-sightedness with exceptional attention to the countless details of a case. She gets great results and is also a nice person to work with."
– IAM Patent 1000, 2023
“An extremely safe pair of hands for complex IP issues and top-level portfolio strategy in the pharmaceutical and biotechnology space, Eva Ehlich is commercially and culturally astute and easily grapples with the complexities and politics of larger international projects.”
– IAM 300, 2022
"Eva Ehlich: Excellent knowledge of the industry; years of experience; excellent strategic thinking; holistic approach."
– Legal 500 DE, 2022
„valuable input regarding FTOs, prosecution and oppositions” (client)
– JUVE Patent, 2021
"The small molecule and biologics know-how of chemist Eva Ehlich is highly prized by pharmaceutical companies across Europe, the United States and Japan."
– IAM Patent 1000, 2021
"Eva Ehlich is another wise choice for international briefs – her focus is on advising innovative US and Japanese pharmaceutical companies on filing strategies and worldwide portfolio management."
– IAM Patent 1000, 2020
"Eva Ehlich stands out due to the rare ability, to combine thoroughness and pragmatism. She delivers excellent results."
– Legal 500 EMEA, 2020